Related references
Note: Only part of the references are listed.No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions
Petrine Wellendorph et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
A comparison of effects on reproduction and neonatal development in cynomolgus monkeys given human soluble IL-4R and mice given murine soluble IL-4R
Linda L. Carlock et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Safety Issues Specific to Clinical Development of Protein Therapeutics
C. A. Haller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of administration of a monoclonal antibody against mouse tumor necrosis factor alpha during pregnancy and lactation on the pre- and postnatal development of the mouse immune system
Pauline L. Martin et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2008)
Safety-related regulatory actions for biologicals approved in the United States and the European Union
Thijs J. Giezen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration
Henrike Veninga et al.
JOURNAL OF IMMUNOLOGY (2008)
The beginning of the end for chimpanzee experiments?
Andrew Knight
Philosophy Ethics and Humanities in Medicine (2008)
Phenotype of a calbindin-D9k gene knockout is compensated for by the induction of other calcium transporter genes in a mouse model
Geun-Shik Lee et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Anti-KC autoantibody:KC complexes cause severe lung inflammation in mice via IgG receptors
Agnieszka Krupa et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Functional rescue of elastin insufficiency in mice by the human elastin gene - Implications for mouse models of human disease
Eiichi Hirano et al.
CIRCULATION RESEARCH (2007)
Effects of an anti-TNF-α monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system
Pauline L. Martin et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2007)
Recombinant rat and mouse growth hormones: Risk assessment of carcinogenic potential in 2-year bioassays in rats and mice
Georgia M. Farris et al.
TOXICOLOGICAL SCIENCES (2007)
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B. Evers et al.
ONCOGENE (2006)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in human immune system Rag2-/- γc-/- mice
N Legrand et al.
BLOOD (2006)
CD28 superagonists put a break on autoimmunity by preferentially activating CD4(+)CD25(+) regulatory T cells
N Beyersdorf et al.
AUTOIMMUNITY REVIEWS (2006)
Compensatory response of IL-1 gene knockout mice after pulmonary infection with Klebsiella pneumoniae
M Tanabe et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay
SM Cohen
TOXICOLOGICAL SCIENCES (2004)
Evaluation of a surrogate antibody for preclinical safety testing of an anti-CD11a monoclonal antibody
J Clarke et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2004)
Lymphotoxin/light, lymphoid microenvironments and autoimmune disease
JL Gommerman et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Species differences in the structure and function of the immune system
PJ Haley
TOXICOLOGY (2003)
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
CH Lin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
A comparison of placental development and endocrine functions between the human and mouse model
A Malassine et al.
HUMAN REPRODUCTION UPDATE (2003)
Practical aspects of including functional endpoints, in developmental toxicity studies.: Case study:: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero
DJ Herzyk et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2002)
Carcinogenicity testing of IL-10: Principles and practicalities
IY Rosenblum et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2002)
Outlook - Preclinical safety evaluation of biotechnology-derived pharmaceuticals
JA Cavagnaro
NATURE REVIEWS DRUG DISCOVERY (2002)
Use of genetically engineered mice in drug discovery and development: Wielding Occam's razor to prune the product portfolio
B Bolon et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2002)
Induction of direct antimicrobial activity through mammalian toll-like receptors
S Thoma-Uszynski et al.
SCIENCE (2001)
Lessons from loricrin-deficient mice: Compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein
PJ Koch et al.
JOURNAL OF CELL BIOLOGY (2000)
Preclinical development of keliximab, a Primatized™ anti-CD4 monoclonal antibody, in human CD4 transgenic mice:: characterization of the model and safety studies
PJ Bugelski et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2000)
Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFα monoclonal antibody
G Treacy
HUMAN & EXPERIMENTAL TOXICOLOGY (2000)
Share Paper
